PCSK7
Proprotein convertase subtilisin/kexin type 7
Also known as: LPC, PC7, PC8, PCSK7_HUMAN, SPC7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16549
- Gene
- PCSK7
- Ensembl
- ENSG00000160613
- Chromosome
- 11
- Canonical length
- 785 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. It encodes a type 1 membrane bound protease that is expressed in many tissues, including neuroendocrine, liver, gut, and brain. The encoded protein undergoes an initial autocatalytic processing event in the ER and then sorts to the trans-Golgi network through endosomes where a second autocatalytic event takes place and the catalytic activity is acquired. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It can process proalbumin and is thought to be responsible for the activation of HIV envelope glycoproteins gp160 and gp140. This gene has been implicated in the transcriptional regulation of housekeeping genes and plays a role in the regulation of iron metabolism. A t(11;14)(q23;q32) chromosome translocation associated with B-cell lymphoma occurs between this gene and its inverted counterpart. [provided by RefSeq, Feb 2014]
Canonical amino-acid sequenceUniProt
785 residues, UniProt reviewed canonical sequence.
>Q16549|PCSK7
1 MPKGRQKVPH LDAPLGLPTC LWLELAGLFL LVPWVMGLAG TGGPDGQGTG GPSWAVHLES
61 LEGDGEEETL EQQADALAQA AGLVNAGRIG ELQGHYLFVQ PAGHRPALEV EAIRQQVEAV
121 LAGHEAVRWH SEQRLLRRAK RSVHFNDPKY PQQWHLNNRR SPGRDINVTG VWERNVTGRG
181 VTVVVVDDGV EHTIQDIAPN YSPEGSYDLN SNDPDPMPHP DVENGNHHGT RCAGEIAAVP
241 NNSFCAVGVA YGSRIAGIRV LDGPLTDSME AVAFNKHYQI NDIYSCSWGP DDDGKTVDGP
301 HQLGKAALQH GVIAGRQGFG SIFVVASGNG GQHNDNCNYD GYANSIYTVT IGAVDEEGRM
361 PFYAEECASM LAVTFSGGDK MLRSIVTTDW DLQKGTGCTE GHTGTSAAAP LAAGMIALML
421 QVRPCLTWRD VQHIIVFTAT RYEDRRAEWV TNEAGFSHSH QHGFGLLNAW RLVNAAKIWT
481 SVPYLASYVS PVLKENKAIP QSPRSLEVLW NVSRMDLEMS GLKTLEHVAV TVSITHPRRG
541 SLELKLFCPS GMMSLIGAPR SMDSDPNGFN DWTFSTVRCW GERARGTYRL VIRDVGDESF
601 QVGILRQWQL TLYGSVWSAV DIRDRQRLLE SAMSGKYLHD DFALPCPPGL KIPEEDGYTI
661 TPNTLKTLVL VGCFTVFWTV YYMLEVYLSQ RNVASNQVCR SGPCHWPHRS RKAKEEGTEL
721 ESVPLCSSKD PDEVETESRG PPTTSDLLAP DLLEQGDWSL SQNKSALDCP HQHLDVPHGK
781 EEQICLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCSK7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- stomach: 43 nTPM
- colon: 43 nTPM
- rectum: 36 nTPM
- lymph node: 29 nTPM
- tonsil: 28 nTPM
- pancreas: 28 nTPM
Single-cell type
- foveolar cells: 189 nCPM
- colonocytes: 179 nCPM
- vascular smooth muscle cells: 169 nCPM
- t-cells: 142 nCPM
- nk-cells: 135 nCPM
- salivary myoepithelial cells: 127 nCPM
Immune cell
- T-reg: 48 nTPM
- NK-cell: 46 nTPM
- gdT-cell: 42 nTPM
- memory CD8 T-cell: 39 nTPM
- MAIT T-cell: 37 nTPM
- memory CD4 T-cell: 33 nTPM
Brain region
- cerebral cortex: 37 nTPM
- hippocampal formation: 35 nTPM
- white matter: 35 nTPM
- thalamus: 32 nTPM
- medulla oblongata: 31 nTPM
- pons: 31 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.49
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S8/S53 domain
- P domain
- Galactose-binding-like domain superfamily
- Peptidase S8, subtilisin-related
- Peptidase S8, subtilisin, His-active site
- Peptidase S8, subtilisin, Ser-active site
- Peptidase S8, pro-domain
- Kexin/furin catalytic domain
- Peptidase S8/S53 domain superfamily
- Peptidase S8, pro-domain superfamily
- Subtilase family
- Proprotein convertase P-domain
- Peptidase S8 pro-domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCSK7 as an antibody target. Whether an autoantibody or antibody against PCSK7 could matter depends on whether native PCSK7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCSK7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCSK7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...